The Study of the Extent of Apoptosis in Patients with Metabolic Syndrome by Assessing the Level of Caspase-8 in Blood Plasma
Abstract
The average level of caspase-8 was significantly higher in the group of patients with MS (p<0.05). There was a positive correlation between the level of caspase-8 and ECHO features of atherosclerosis of the aorta, the presence of diabetes mellitus type 2, thick epicardial fat, the presence of gastroesophageal reflux disease, increased activity of serum transaminases, steatosis of the liver and pancreas.
About the Authors
O. M. DrapkinaRussian Federation
R. N. Shepel
Russian Federation
T. A. Deeva
Russian Federation
References
1. Chernysheva E. N., Panova T. N. Biologicheskij vozrast i koehfficient skorosti stareniya u bol'nyh s metabolicheskim sindromom v zavisimosti ot antropometricheskih pokazatelej [Biological age and rate of aging in patients with metabolic syndrome depending on the anthropometric indicators]. Kubanskij nauchnyy medicmskij vestnik, 2011, no 6, pp. 178-181. (in Russian).
2. Drapkina O. M.,Shepel R. N. Gipodinamiya - bolezn' veka: nizkaya fizicheskaya aktivnost kak faktor riska zabolevanij serdechno-sosudistoj sistemy i prezhdevremennogo stareniya [Physical inactivity is a disease of the century: physical inactivity as risk factor for diseases of the cardiovascular system and premature aging]. Kardiologiya: novosti, mneniya, obuchenie, 2015, no 3, pp. 53-58. (in Russian).
3. Drapkina 0. M., Shepel' R. N. Omega-3 polinenasyshchennye zhirnye kisloty i vozrast- associirovannye bolezni: realii i perspektivy. [Omega-3 polyunsaturated fatty acids and age-associated diseases: realities and prospects]. Raaonal'naya farmakoterapiya v kardiologii, 2015, vol. 11, no 3, pp.309-316. (in Russian).
4. Storozhakov G. I., Uteshev D. B. Rol' apoptoza v razvitii ateroskleroza, ishemii miokarda
5. i serdechnoj nedostatochnosti. [The role of apoptosis in the development of atherosclerosis, myocardial ischemia and heart failure]. Serdechno-sosudistaya hirurgiya, 2000, no 7, pp. 7-11. (in Russian).
6. Garg S., Narula J., Chandrashekhar Y. Apoptosis and heart failure: clinical relevance and therapeutic target. J Mol Cell Cardiol, 2005, vol. 38, no 1, pp. 73-79.
7. Okere I. C., Chandler M. P., McElfresh T.A., Rennison J. H., Sharov V., Sabbah H. N., Tserng K. Y., Hoit B. D., Ernsberger P., Young M. E., Stanley W. C. Differential effects of saturated and unsaturated fatty acid diets on cardiomyocyte apoptosis, adipose distribution, serum leptin. Am J Physiol Heart Circ Physiol, 2006, vol. 291, no.1, pp. H38-H44.
8. Yousef Z. R., Redwood S. R., Marber M. S. Post-infarction left ventricular remodelling: a pathophysiological andtherapeutic review. CardiovascularDrugs Ther, 2000, vol. 14, no 3, pp. 243-252.
9. Olivetti G., Abbi R., Quaini F., Kajstura J., Cheng W., Nitahara J. A., Quaini E., Di Loreto C., Beltrami C. A., Krajewski S., Reed J. C., Anversa P. Apoptosis in the failing human heart. New Engl. J. Med, 1997, vol. 336, no. 16, pp. 1131-1141.
10. Alberti K. G.M.M., Zimmet P. Z., Shaw J. E. The metabolic syndrome - a new worldwide definition from the International Diabetes Federation Consensus. Lancet, 2005, vol. 366, pp. 1059-1062
Review
For citations:
Drapkina O.M., Shepel R.N., Deeva T.A. The Study of the Extent of Apoptosis in Patients with Metabolic Syndrome by Assessing the Level of Caspase-8 in Blood Plasma. Emergency Cardiology and Cardiovascular Risks journal. 2017;1(1):78-82. (In Russ.)









